(Press-News.org) JUPITER, FL, September 4, 2014 - In a collaborative study, scientists from the Florida campus of The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology have developed a more effective method to determine how immune cells called T cells differentiate into specialized types of cells that help eradicate infected cells and assist other immune cells during infection.
The new approach, published recently by the journal Immunity, could help accelerate laboratory research and the development of potential therapeutics, including vaccines. The method may also be used to identify the genes that underlie tumor cell development.
There are approximately 40,000 genes in each of our cells, but functions for only about half of them are known. The classical approach to determine the function of individual genes is slow.
"Typically, studies to identify differentiation players are done one gene at a time," said Associate Professor Matthew Pipkin of TSRI, who led the study with Professor Shane Crotty of the La Jolla Institute for Allergy and Immunology. "Our study describes a novel method that can 'screen' entire gene families to discover the functions of a large number of individual genes simultaneously, a far more efficient methodology."
In the new study, the team examined genes that regulate the specialization of T cells into "effector" cells that eliminate pathogens during infection and "memory" cells that survive long-term to maintain guard after the first infection has been cleared, keeping the same pathogens from re-infecting the body after it has fought them off once.
In their experiments, Pipkin, Crotty and their colleagues created a mixture of T cells, identical except that the expression of a different gene was interrupted in each cell so the pool of cells represented disruption of a large set of genes. The researchers then assessed the cells' response to lymphocytic choriomeningitis virus (LCMV). Before-and-after-infection studies revealed which cells with interrupted genes had emerged after infection; cells in which disruption of a particular gene resulted in it being lost from the mixture indicated the gene played a role in promoting the cell's development into an antiviral T cell.
The study successfully identified two previously unknown factors that work together during T cell differentiation—Cyclin T1 and its catalytic partner Cdk9, which together form the transcription elongation factor (P-TEFb). While widely expressed throughout the body and used in a number of developmental processes, the factors were previously unknown to be important in the differentiation of both antiviral CD4 and CD8 T cells.
"One of the regulators we uncovered normally enhances effector T cell differentiation at the expense of generating memory T cells and T cells that orchestrate antibody production," Pipkin said. "That's one candidate that you'd want to 'turn down' if you wanted to create more T cells that form memory cells and promote a more effective antibody response—something that would be extremely helpful in developing a vaccine."
INFORMATION:
The first authors of the study, "In Vivo RNA Interference Screens Identify Regulators of Antiviral CD4+ and CD8+ T Cell Differentiation," are Runqiang Chen and Simon Bélanger of the La Jolla Institute for Allergy and Immunology. Other authors include Megan A. Frederick of TSRI; and Bin Li, Robert J. Johnston, Nengming Xiao, Yun-Cai Liu, Sonia Sharma, Bjoern Peters and Anjana Rao of the La Jolla Institute for Allergy and Immunology. See http://www.cell.com/immunity/abstract/S1074-7613(14)00272-6
This work was supported by the National Institutes of Health (RC4 AI092763, R01 AI095634, R01 CA42471, R01 072543 and U19 AI109976) and Frenchman's Creek Women for Cancer Research.
Team identifies important regulators of immune cell response
2014-09-04
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Knowing how bacteria take out trash could lead to new antibiotics
2014-09-04
AMHERST, Mass. – A collaborative team of scientists including biochemist Peter Chien at the University of Massachusetts Amherst has reconstructed how bacteria tightly control their growth and division, a process known as the cell cycle, by specifically destroying key proteins through regulated protein degradation.
Regulated protein degradation uses specific enzymes called energy dependent proteases to selective destroy certain targets. Because regulated protein degradation is critical for bacterial virulence and invasion, understanding how these proteases function should ...
Reacting to personal setbacks: Do you bounce back or give up?
2014-09-04
Sometimes when people get upsetting news – such as a failing exam grade or a negative job review – they decide instantly to do better the next time. In other situations that are equally disappointing, the same people may feel inclined to just give up.
How can similar setbacks produce such different reactions? It may come down to how much control we feel we have over what happened, according to new research from Rutgers University-Newark.
The study, published in the journal Neuron, also finds that when these setbacks occur, the level of control we perceive may even determine ...
Plant-based research at Penn prevents complication of hemophilia treatment in mice
2014-09-04
While healthy people have proteins in their blood called clotting factors that act quickly to plug wounds, hemophiliacs lack these proteins, making even minor bleeds difficult to stop.
The main treatment option for people with severe hemophilia is to receive regular infusions of clotting factor. But 20 to 30 percent of people who get these infusions develop antibodies, called inhibitors, against the clotting factor. Once these inhibitors develop, it can be very difficult to treat or prevent future bleeding episodes.
In a new study, researchers from the University of ...
LSU Health research discovers new therapeutic target for diabetic wound healing
2014-09-04
New Orleans, LA – Research led by scientists in Dr. Song Hong's group at LSU Health New Orleans has identified a novel family of chemical mediators that rescue the reparative functions of macrophages (a main type of mature white blood cells) impaired by diabetes, restoring their ability to resolve inflammation and heal wounds. The research is in-press and is scheduled to be published in the October 23, 2014 issue of Chemistry & Biology, a Cell Press journal.
The white blood cells, or leukocytes, of the immune system, help defend the body against infection or foreign ...
Study shows complexities of reducing HIV rates in Russia
2014-09-04
(Boston) – Results of a new study conducted in St. Petersburg, Russia, show that decreasing HIV transmission among Russian HIV-infected drinkers will require creative and innovative approaches.
While new HIV infections globally have declined, HIV rates remain high in Russia. This is due in large part to injection drug use and spread via heterosexual sex transmission. Alcohol use also has been shown to be related to risky sexual behaviors and sexually transmitted infections (STIs).
Published online in Addiction, the study showed that a behavioral intervention did not ...
AGU: Ozone pollution in India kills enough crops to feed 94 million in poverty
2014-09-04
WASHINGTON, D.C. – In one year, India's ozone pollution damaged millions of tons of the country's major crops, causing losses of more than a billion dollars and destroying enough food to feed tens of millions of people living below the poverty line.
These are findings /of a new study that looked at the agricultural effects in 2005 of high concentrations of ground-level ozone, a plant-damaging pollutant formed by emissions from vehicles, cooking stoves and other sources. Able to acquire accurate crop production data for 2005, the study's authors chose it as a year representative ...
Greener neighborhoods lead to better birth outcomes, new research shows
2014-09-04
CORVALLIS, Ore. – Mothers who live in neighborhoods with plenty of grass, trees or other green vegetation are more likely to deliver at full term and their babies are born at higher weights, compared to mothers who live in urban areas that aren't as green, a new study shows.
The findings held up even when results were adjusted for factors such as neighborhood income, exposure to air pollution, noise, and neighborhood walkability, according to researchers at Oregon State University and the University of British Columbia.
"This was a surprise," said Perry Hystad, an environmental ...
Scientists prove ground and tree salamanders have same diets
2014-09-04
Salamanders spend the vast majority of their lives below ground and surface only for short periods of time and usually only on wet nights. When they do emerge, salamanders can be spotted not only on forest floors but also up in trees and on other vegetation, often climbing as high as 8 feet. Given their infrequent appearances aboveground, it has never been clear to biologists why salamanders take time to climb vegetation. Researchers at the University of Missouri recently conducted a study testing a long-standing hypothesis that salamanders might climb vegetation for food. ...
Public trust has dwindled with rise in income inequality
2014-09-04
Trust in others and confidence in societal institutions are at their lowest point in over three decades, analyses of national survey data reveal. The findings are forthcoming in Psychological Science, a journal of the Association for Psychological Science.
"Compared to Americans in the 1970s-2000s, Americans in the last few years are less likely to say they can trust others, and are less likely to believe that institutions such as government, the press, religious organizations, schools, and large corporations are 'doing a good job,'" explains psychological scientist and ...
Researchers turn to plants to help treat hemophilia
2014-09-04
GAINESVILLE, Fla. — Accidents as minor as a slip of the knife while chopping onions can turn dangerous for patients with hemophilia, who lack the necessary proteins in their blood to stem the flow from a wound.
People with severe hemophilia typically receive regular injections of these proteins, called clotting factors, as a treatment for the disease. But up to 30 percent of people with the most common form, hemophilia A, develop antibodies that attack these lifesaving proteins, making it difficult to prevent or treat excessive bleeding.
Now, researchers from University ...